Cargando…
TET enzymes control antibody production and shape the mutational landscape in germinal centre B cells
Upon activation by antigen, B cells form germinal centres where they clonally expand and introduce affinity‐enhancing mutations into their B‐cell receptor genes. Somatic mutagenesis and class switch recombination (CSR) in germinal centre B cells are initiated by the activation‐induced cytidine deami...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6851767/ https://www.ncbi.nlm.nih.gov/pubmed/31120187 http://dx.doi.org/10.1111/febs.14934 |
_version_ | 1783469682172362752 |
---|---|
author | Schoeler, Katia Aufschnaiter, Andreas Messner, Simon Derudder, Emmanuel Herzog, Sebastian Villunger, Andreas Rajewsky, Klaus Labi, Verena |
author_facet | Schoeler, Katia Aufschnaiter, Andreas Messner, Simon Derudder, Emmanuel Herzog, Sebastian Villunger, Andreas Rajewsky, Klaus Labi, Verena |
author_sort | Schoeler, Katia |
collection | PubMed |
description | Upon activation by antigen, B cells form germinal centres where they clonally expand and introduce affinity‐enhancing mutations into their B‐cell receptor genes. Somatic mutagenesis and class switch recombination (CSR) in germinal centre B cells are initiated by the activation‐induced cytidine deaminase (AID). Upon germinal centre exit, B cells differentiate into antibody‐secreting plasma cells. Germinal centre maintenance and terminal fate choice require transcriptional reprogramming that associates with a substantial reconfiguration of DNA methylation patterns. Here we examine the role of ten‐eleven‐translocation (TET) proteins, enzymes that facilitate DNA demethylation and promote a permissive chromatin state by oxidizing 5‐methylcytosine, in antibody‐mediated immunity. Using a conditional gene ablation strategy, we show that TET2 and TET3 guide the transition of germinal centre B cells to antibody‐secreting plasma cells. Optimal AID expression requires TET function, and TET2 and TET3 double‐deficient germinal centre B cells show defects in CSR. However, TET2/TET3 double‐deficiency does not prevent the generation and selection of high‐affinity germinal centre B cells. Rather, combined TET2 and TET3 loss‐of‐function in germinal centre B cells favours C‐to‐T and G‐to‐A transition mutagenesis, a finding that may be of significance for understanding the aetiology of B‐cell lymphomas evolving in conditions of reduced TET function. |
format | Online Article Text |
id | pubmed-6851767 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-68517672019-11-18 TET enzymes control antibody production and shape the mutational landscape in germinal centre B cells Schoeler, Katia Aufschnaiter, Andreas Messner, Simon Derudder, Emmanuel Herzog, Sebastian Villunger, Andreas Rajewsky, Klaus Labi, Verena FEBS J Editor's Choice Upon activation by antigen, B cells form germinal centres where they clonally expand and introduce affinity‐enhancing mutations into their B‐cell receptor genes. Somatic mutagenesis and class switch recombination (CSR) in germinal centre B cells are initiated by the activation‐induced cytidine deaminase (AID). Upon germinal centre exit, B cells differentiate into antibody‐secreting plasma cells. Germinal centre maintenance and terminal fate choice require transcriptional reprogramming that associates with a substantial reconfiguration of DNA methylation patterns. Here we examine the role of ten‐eleven‐translocation (TET) proteins, enzymes that facilitate DNA demethylation and promote a permissive chromatin state by oxidizing 5‐methylcytosine, in antibody‐mediated immunity. Using a conditional gene ablation strategy, we show that TET2 and TET3 guide the transition of germinal centre B cells to antibody‐secreting plasma cells. Optimal AID expression requires TET function, and TET2 and TET3 double‐deficient germinal centre B cells show defects in CSR. However, TET2/TET3 double‐deficiency does not prevent the generation and selection of high‐affinity germinal centre B cells. Rather, combined TET2 and TET3 loss‐of‐function in germinal centre B cells favours C‐to‐T and G‐to‐A transition mutagenesis, a finding that may be of significance for understanding the aetiology of B‐cell lymphomas evolving in conditions of reduced TET function. John Wiley and Sons Inc. 2019-06-03 2019-09 /pmc/articles/PMC6851767/ /pubmed/31120187 http://dx.doi.org/10.1111/febs.14934 Text en © 2019 The Authors. The FEBS Journal published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Editor's Choice Schoeler, Katia Aufschnaiter, Andreas Messner, Simon Derudder, Emmanuel Herzog, Sebastian Villunger, Andreas Rajewsky, Klaus Labi, Verena TET enzymes control antibody production and shape the mutational landscape in germinal centre B cells |
title |
TET enzymes control antibody production and shape the mutational landscape in germinal centre B cells |
title_full |
TET enzymes control antibody production and shape the mutational landscape in germinal centre B cells |
title_fullStr |
TET enzymes control antibody production and shape the mutational landscape in germinal centre B cells |
title_full_unstemmed |
TET enzymes control antibody production and shape the mutational landscape in germinal centre B cells |
title_short |
TET enzymes control antibody production and shape the mutational landscape in germinal centre B cells |
title_sort | tet enzymes control antibody production and shape the mutational landscape in germinal centre b cells |
topic | Editor's Choice |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6851767/ https://www.ncbi.nlm.nih.gov/pubmed/31120187 http://dx.doi.org/10.1111/febs.14934 |
work_keys_str_mv | AT schoelerkatia tetenzymescontrolantibodyproductionandshapethemutationallandscapeingerminalcentrebcells AT aufschnaiterandreas tetenzymescontrolantibodyproductionandshapethemutationallandscapeingerminalcentrebcells AT messnersimon tetenzymescontrolantibodyproductionandshapethemutationallandscapeingerminalcentrebcells AT derudderemmanuel tetenzymescontrolantibodyproductionandshapethemutationallandscapeingerminalcentrebcells AT herzogsebastian tetenzymescontrolantibodyproductionandshapethemutationallandscapeingerminalcentrebcells AT villungerandreas tetenzymescontrolantibodyproductionandshapethemutationallandscapeingerminalcentrebcells AT rajewskyklaus tetenzymescontrolantibodyproductionandshapethemutationallandscapeingerminalcentrebcells AT labiverena tetenzymescontrolantibodyproductionandshapethemutationallandscapeingerminalcentrebcells |